Market Cap
Bristol-Myers Squibb Company
$96.93 Billion
USD as of July 1, 2025
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Roche | $260.54 B | 
|  Novartis | $243.50 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Bristol Myers Squibb Company, also known as BMS, is a multinational pharmaceutical company. Tracing its origins to1858, it develops and manufactures prescription pharmaceuticals and biologics for a diverse range of diseases including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
 United States
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                            United States
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—General
                     United States Healthcare
                                United States Healthcare
                        
                             United States Drug Manufacturers—General
                            United States Drug Manufacturers—General
                    
                    The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.